On January 24, Northeast Public Radio aired an interview with Dr. Ana Langer about the Global Gag Rule as part of its weekly Health Show.
Listen to the four-and-a-half-minute interview online.
On January 24, Northeast Public Radio aired an interview with Dr. Ana Langer about the Global Gag Rule as part of its weekly Health Show.
Listen to the four-and-a-half-minute interview online.
EngenderHealth is thrilled to announce that President Barack Obama has rescinded the Global Gag Rule!
Thanks to all of you who signed our petition and made your voices heard. Your involvement and commitment paid off.
This is only the first of many positive changes to come, and there is still much work to be done to advance sexual and reproductive health. EngenderHealth has identified the top 5 actions for the Obama Administration, including investing more in international family planning programs, which remain severely underfunded. We will be mobilizing around this and other reproductive health priorities in the coming months. Stay tuned!
A final rule (PDF, 76KB) on USAID’s Partner Vetting System (PVS) was published January 2, in the Federal Register.
The PVS rule requires recipients of USAID funds to collect and submit personal information on its principal officers that government personnel could use for security screening. When the rule was first proposed in 2007, EngenderHealth, along with other organizations, voiced concerns over the requirement, which violates civil rights protected by the Privacy Act of 1974 and could jeopardize the safety of employees working in developing countries.
The rule goes into effect 30 days from the date of publication, and it will be up to the incoming Obama administration to decide whether it wants to implement the PVS. We will continue to keep you informed on the latest developments regarding this rule.
This article reports on qualitative research investigating key challenges and barriers towards human papillomavirus (HPV) vaccine introduction in the Western Cape Province, South Africa. A total of 50 in-depth interviews and 6 focus groups were conducted at policy, health service and community levels of enquiry. Respondents expressed overall support for the HPV vaccine, underscored by difficulties associated with the current cervical screening programmes and the burgeoning HIV/AIDS epidemic in South Africa. Overall poor community knowledge of cervical cancer and the causal relationship between HPV and cervical cancer suggests the need for continued education around the importance of regular cervical screening. The optimal target populations for HPV vaccination was influenced by the perceived median age of sexual activity in South African girls (9-15 years), with an underlying concern that high levels of sexual abuse had significantly decreased the age of sexual exposure suggesting vaccination should commence as early as 9 years. Vaccination through schools with the involvement of other stakeholders such as sexual and reproductive health and the advanced programme on immunization (EPI) were suggested. Opposition to the HPV vaccine was not anticipated if the vaccine was marketed as preventing cervical cancer rather than a sexually transmitted infection. The findings assist in identifying potential barriers and facilitating factors towards HPV vaccines and will inform the development of policy and programs to support HPV vaccination introduction in South Africa and other African countries.